BIO4 Campus attended the European Digital HealthTech Conference 2026 in Luxembourg, organized by Luxinnovation GIE, where discussions centered on questions shaping the future of healthcare and biotech in Europe.

Conversations focused on the implementation of the EU AI Act and the proposed Biotech Act, and what both could mean for the broader European innovation ecosystem. The event provided insight into how industry, research, policy, and healthcare stakeholders are navigating regulatory frameworks, digital transformation, and cross-border collaboration.

Following European trends in digital medicine and biotech

Events like this are valuable not only for the topics on the agenda, but for showing where the conversation is actually moving across sectors. For BIO4 Campus, it was an opportunity to follow these developments more closely and stay connected to the wider European landscape shaping digital medicine and biotechnology.

The participation reinforced BIO4's engagement with European policy discussions and innovation networks, helping position Serbia's life sciences ecosystem within the regulatory and technological trends defining the continent's biotech future.